| The role of the helper lipid on the DNA transfection efficiency of lipopolyplex formulations Z Du, MM Munye, AD Tagalakis, MDI Manunta, SL Hart Scientific reports 4 (1), 1-6, 2014 | 191 | 2014 |
| X-linked primary ciliary dyskinesia due to mutations in the cytoplasmic axonemal dynein assembly factor PIH1D3 C Olcese, MP Patel, A Shoemark, S Kiviluoto, M Legendre, HJ Williams, ... Nature communications 8 (1), 14279, 2017 | 148 | 2017 |
| Nonintegrating gene therapy vectors T Athanasopoulos, MM Munye, RJ Yáñez-Muñoz Hematology/Oncology Clinics 31 (5), 753-770, 2017 | 117 | 2017 |
| Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm A Onoufriadis, A Shoemark, MM Munye, CT James, M Schmidts, M Patel, ... Journal of medical genetics, jmedgenet-2013-101938, 2014 | 106 | 2014 |
| Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer MM Munye, AD Tagalakis, JL Barnes, RE Brown, RJ McAnulty, SJ Howe, ... Scientific reports 6 (1), 23125, 2016 | 81 | 2016 |
| Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery AD Tagalakis, DL Do Hyang, AS Bienemann, H Zhou, MM Munye, ... Biomaterials 35 (29), 8406-8415, 2014 | 79 | 2014 |
| Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung AD Tagalakis, MM Munye, R Ivanova, H Chen, CM Smith, AM Aldossary, ... Thorax 73 (9), 847-856, 2018 | 69 | 2018 |
| COLEC10 is mutated in 3MC patients and regulates early craniofacial development MM Munye, A Diaz-Font, L Ocaka, ML Henriksen, M Lees, A Brady, ... PLoS genetics 13 (3), e1006679, 2017 | 68 | 2017 |
| Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis MDI Manunta, AD Tagalakis, M Attwood, AM Aldossary, JL Barnes, ... Scientific reports 7 (1), 700, 2017 | 65 | 2017 |
| PEGylation improves the receptor-mediated transfection efficiency of peptide-targeted, self-assembling, anionic nanocomplexes AD Tagalakis, GD Kenny, AS Bienemann, D McCarthy, MM Munye, ... Journal of Controlled Release 174, 177-187, 2014 | 56 | 2014 |
| Role of liposome and peptide in the synergistic enhancement of transfection with a lipopolyplex vector MM Munye, J Ravi, AD Tagalakis, D McCarthy, MG Ryadnov, SL Hart Scientific reports 5 (1), 9292, 2015 | 53 | 2015 |
| BMI-1 extends proliferative potential of human bronchial epithelial cells while retaining their mucociliary differentiation capacity MM Munye, A Shoemark, RA Hirst, JM Delhove, TV Sharp, TR McKay, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 312 (2 …, 2017 | 49 | 2017 |
| Improved intracellular delivery of peptide-and lipid-nanoplexes by natural glycosides A Weng, MDI Manunta, M Thakur, R Gilabert-Oriol, AD Tagalakis, ... Journal of controlled release 206, 75-90, 2015 | 35 | 2015 |
| A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency AD Tagalakis, S Castellaro, H Zhou, A Bienemann, MM Munye, ... International journal of nanomedicine, 2673-2683, 2015 | 19 | 2015 |
| Integrin‐Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor‐Specific Delivery Achieve MYCN Silencing with Improved Survival AD Tagalakis, V Jayarajan, R Maeshima, KH Ho, F Syed, LP Wu, ... Advanced Functional Materials 31 (37), 2104843, 2021 | 14 | 2021 |
| A nanosensor toolbox for rapid, label-free measurement of airway surface liquid and epithelial cell function R Ivanova, DCH Benton, MM Munye, S Rangseesorranan, SL Hart, ... ACS applied materials & interfaces 11 (9), 8731-8739, 2019 | 9 | 2019 |
| Development of process analytical technology to monitor the cell secretome during differentiation of pluripotent stem cells CP Ricardo, I Evie, M Henry, JM Sanchez-Nieto, M Jayawardena, A Soula, ... Cytotherapy 22 (5), S45-S46, 2020 | | 2020 |
| Development of an end-to-end platform for the controlled, closed, scalable and cost-effective manufacture of allogeneic therapies derived from pluripotent stem cells in … N Agabalyan, MF Mata, J Guenat, IA Valero, H Galali, E Chikunova, ... Cytotherapy 22 (5), S40, 2020 | | 2020 |
| Non-Viral Gene Delivery-Supporting the Next Generation of Gene-Edited Cell Therapies TR Thwaites, I Santeramo, R Petrovic, J Kearney, M Munye, M Bagnati, ... MOLECULAR THERAPY 28 (4), 288-289, 2020 | | 2020 |
| Targeting the tumour vasculature with CAR T-cells for treatment of solid tumours JM Sánchez-Nieto, JJ Guijaro-Leach, R Camicia, A Keogh, CP Ricardo, ... | | 2019 |
